Mothers need to receive realistic, consistent and evidence-based information on breastfeeding [ 48] and a combination of group and individual counselling is more efficient for breast-feeding success [ 49].
So, pretreatment with lower dose of T3 until the end of chemotherapy may be a safer and more efficient therapy for breast cancer patients.
Taxol works differently by arresting the cells in G2-M phase, considering a higher concentration of T3 may be more efficient in promoting breast cancer cells proliferation, we used 24 ng/ml T3 to pretreat MCF-7 or MDA-MB-231, the results showed that both MCF-7 and MDA-MB-231 pretreated with T3 were more sensitive to Taxol than those with Taxol only, without T3 pretreatment (P<0.05).
Data from the present study may help in the development of more efficient therapeutic approaches in breast cancer, addressing the need to target simultaneously multiple molecules that are relevant to this early step of breast cancer progression.
While each take a different approach, a common theme emerges: not only do these companies want to make pumping breast milk more efficient, they also want to give women their comfort and dignity back.
In comparison with free DTX, NPs were both more efficient in inhibiting cell growth of breast and prostate cancer cells and less toxic in experimental animal models.
Second, our active-set method is more efficient than the proximal method on Breast data.
Our data seem to confirm that breast units are more efficient, not only in terms of patient survival (as already shown by Peltoniemi et al) 23 but also in terms of a prompt diagnosis, especially when a triage system is implemented, and with regard to costs.
However, our results show that such guidelines can benefit individual breast cancer patients with more efficient and accurate treatment decisions.
Pharmacokinetic studies indicated that some of the ALA HPO conjugates are more efficient than ALA for PpIX production in the human breast adenocarcinoma cell line (MDA-MB-468).
